Respiratory Syncytial Virus Diagnostics Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Syncytial Virus Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Direct Fluorescent Antibody Method
1.2.3 Rapid Antigen Diagnostic Tests
1.2.4 Molecular Diagnostics
1.2.5 Chromatographic Immunoassay
1.2.6 Diagnostic Imaging
1.2.7 Gel Microdroplets
1.2.8 Flow Cytometry
1.2.9 Other
1.3 Market by Application
1.3.1 Global Respiratory Syncytial Virus Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Laboratory
1.3.4 Clinics
1.3.5 Homecare
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Syncytial Virus Diagnostics Market Perspective (2017-2028)
2.2 Respiratory Syncytial Virus Diagnostics Growth Trends by Region
2.2.1 Respiratory Syncytial Virus Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Respiratory Syncytial Virus Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Respiratory Syncytial Virus Diagnostics Market Dynamics
2.3.1 Respiratory Syncytial Virus Diagnostics Industry Trends
2.3.2 Respiratory Syncytial Virus Diagnostics Market Drivers
2.3.3 Respiratory Syncytial Virus Diagnostics Market Challenges
2.3.4 Respiratory Syncytial Virus Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Syncytial Virus Diagnostics Players by Revenue
3.1.1 Global Top Respiratory Syncytial Virus Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Respiratory Syncytial Virus Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Respiratory Syncytial Virus Diagnostics Revenue
3.4 Global Respiratory Syncytial Virus Diagnostics Market Concentration Ratio
3.4.1 Global Respiratory Syncytial Virus Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Syncytial Virus Diagnostics Revenue in 2021
3.5 Respiratory Syncytial Virus Diagnostics Key Players Head office and Area Served
3.6 Key Players Respiratory Syncytial Virus Diagnostics Product Solution and Service
3.7 Date of Enter into Respiratory Syncytial Virus Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Syncytial Virus Diagnostics Breakdown Data by Type
4.1 Global Respiratory Syncytial Virus Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Type (2023-2028)
5 Respiratory Syncytial Virus Diagnostics Breakdown Data by Application
5.1 Global Respiratory Syncytial Virus Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Respiratory Syncytial Virus Diagnostics Market Size (2017-2028)
6.2 North America Respiratory Syncytial Virus Diagnostics Market Size by Type
6.2.1 North America Respiratory Syncytial Virus Diagnostics Market Size by Type (2017-2022)
6.2.2 North America Respiratory Syncytial Virus Diagnostics Market Size by Type (2023-2028)
6.2.3 North America Respiratory Syncytial Virus Diagnostics Market Share by Type (2017-2028)
6.3 North America Respiratory Syncytial Virus Diagnostics Market Size by Application
6.3.1 North America Respiratory Syncytial Virus Diagnostics Market Size by Application (2017-2022)
6.3.2 North America Respiratory Syncytial Virus Diagnostics Market Size by Application (2023-2028)
6.3.3 North America Respiratory Syncytial Virus Diagnostics Market Share by Application (2017-2028)
6.4 North America Respiratory Syncytial Virus Diagnostics Market Size by Country
6.4.1 North America Respiratory Syncytial Virus Diagnostics Market Size by Country (2017-2022)
6.4.2 North America Respiratory Syncytial Virus Diagnostics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Respiratory Syncytial Virus Diagnostics Market Size (2017-2028)
7.2 Europe Respiratory Syncytial Virus Diagnostics Market Size by Type
7.2.1 Europe Respiratory Syncytial Virus Diagnostics Market Size by Type (2017-2022)
7.2.2 Europe Respiratory Syncytial Virus Diagnostics Market Size by Type (2023-2028)
7.2.3 Europe Respiratory Syncytial Virus Diagnostics Market Share by Type (2017-2028)
7.3 Europe Respiratory Syncytial Virus Diagnostics Market Size by Application
7.3.1 Europe Respiratory Syncytial Virus Diagnostics Market Size by Application (2017-2022)
7.3.2 Europe Respiratory Syncytial Virus Diagnostics Market Size by Application (2023-2028)
7.3.3 Europe Respiratory Syncytial Virus Diagnostics Market Share by Application (2017-2028)
7.4 Europe Respiratory Syncytial Virus Diagnostics Market Size by Country
7.4.1 Europe Respiratory Syncytial Virus Diagnostics Market Size by Country (2017-2022)
7.4.2 Europe Respiratory Syncytial Virus Diagnostics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Type
8.2.1 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Share by Type (2017-2028)
8.3 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Application
8.3.1 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Share by Application (2017-2028)
8.4 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Region
8.4.1 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Respiratory Syncytial Virus Diagnostics Market Size (2017-2028)
9.2 Latin America Respiratory Syncytial Virus Diagnostics Market Size by Type
9.2.1 Latin America Respiratory Syncytial Virus Diagnostics Market Size by Type (2017-2022)
9.2.2 Latin America Respiratory Syncytial Virus Diagnostics Market Size by Type (2023-2028)
9.2.3 Latin America Respiratory Syncytial Virus Diagnostics Market Share by Type (2017-2028)
9.3 Latin America Respiratory Syncytial Virus Diagnostics Market Size by Application
9.3.1 Latin America Respiratory Syncytial Virus Diagnostics Market Size by Application (2017-2022)
9.3.2 Latin America Respiratory Syncytial Virus Diagnostics Market Size by Application (2023-2028)
9.3.3 Latin America Respiratory Syncytial Virus Diagnostics Market Share by Application (2017-2028)
9.4 Latin America Respiratory Syncytial Virus Diagnostics Market Size by Country
9.4.1 Latin America Respiratory Syncytial Virus Diagnostics Market Size by Country (2017-2022)
9.4.2 Latin America Respiratory Syncytial Virus Diagnostics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Type
10.2.1 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Share by Type (2017-2028)
10.3 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Application
10.3.1 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Share by Application (2017-2028)
10.4 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Country
10.4.1 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Becton Dickinson
11.1.1 Becton Dickinson Company Details
11.1.2 Becton Dickinson Business Overview
11.1.3 Becton Dickinson Respiratory Syncytial Virus Diagnostics Introduction
11.1.4 Becton Dickinson Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
11.1.5 Becton Dickinson Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Respiratory Syncytial Virus Diagnostics Introduction
11.2.4 Abbott Laboratories Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
11.2.5 Abbott Laboratories Recent Developments
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Respiratory Syncytial Virus Diagnostics Introduction
11.3.4 Abbott Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
11.3.5 Abbott Recent Developments
11.4 Beckman Coulter/Danaher
11.4.1 Beckman Coulter/Danaher Company Details
11.4.2 Beckman Coulter/Danaher Business Overview
11.4.3 Beckman Coulter/Danaher Respiratory Syncytial Virus Diagnostics Introduction
11.4.4 Beckman Coulter/Danaher Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
11.4.5 Beckman Coulter/Danaher Recent Developments
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Details
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories Respiratory Syncytial Virus Diagnostics Introduction
11.5.4 Bio-Rad Laboratories Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
11.5.5 Bio-Rad Laboratories Recent Developments
11.6 Coris BioConcept
11.6.1 Coris BioConcept Company Details
11.6.2 Coris BioConcept Business Overview
11.6.3 Coris BioConcept Respiratory Syncytial Virus Diagnostics Introduction
11.6.4 Coris BioConcept Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
11.6.5 Coris BioConcept Recent Developments
11.7 DiaSorin SPA
11.7.1 DiaSorin SPA Company Details
11.7.2 DiaSorin SPA Business Overview
11.7.3 DiaSorin SPA Respiratory Syncytial Virus Diagnostics Introduction
11.7.4 DiaSorin SPA Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
11.7.5 DiaSorin SPA Recent Developments
11.8 Eiken Chemical
11.8.1 Eiken Chemical Company Details
11.8.2 Eiken Chemical Business Overview
11.8.3 Eiken Chemical Respiratory Syncytial Virus Diagnostics Introduction
11.8.4 Eiken Chemical Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
11.8.5 Eiken Chemical Recent Developments
11.9 Elitech
11.9.1 Elitech Company Details
11.9.2 Elitech Business Overview
11.9.3 Elitech Respiratory Syncytial Virus Diagnostics Introduction
11.9.4 Elitech Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
11.9.5 Elitech Recent Developments
11.10 Fujirebio
11.10.1 Fujirebio Company Details
11.10.2 Fujirebio Business Overview
11.10.3 Fujirebio Respiratory Syncytial Virus Diagnostics Introduction
11.10.4 Fujirebio Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
11.10.5 Fujirebio Recent Developments
11.11 Grifols
11.11.1 Grifols Company Details
11.11.2 Grifols Business Overview
11.11.3 Grifols Respiratory Syncytial Virus Diagnostics Introduction
11.11.4 Grifols Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
11.11.5 Grifols Recent Developments
11.12 Hoffmann La Roche
11.12.1 Hoffmann La Roche Company Details
11.12.2 Hoffmann La Roche Business Overview
11.12.3 Hoffmann La Roche Respiratory Syncytial Virus Diagnostics Introduction
11.12.4 Hoffmann La Roche Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
11.12.5 Hoffmann La Roche Recent Developments
11.13 Hologic
11.13.1 Hologic Company Details
11.13.2 Hologic Business Overview
11.13.3 Hologic Respiratory Syncytial Virus Diagnostics Introduction
11.13.4 Hologic Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
11.13.5 Hologic Recent Developments
11.14 Novartis Diagnostics
11.14.1 Novartis Diagnostics Company Details
11.14.2 Novartis Diagnostics Business Overview
11.14.3 Novartis Diagnostics Respiratory Syncytial Virus Diagnostics Introduction
11.14.4 Novartis Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
11.14.5 Novartis Diagnostics Recent Developments
11.15 Ortho Clinical Diagnostics
11.15.1 Ortho Clinical Diagnostics Company Details
11.15.2 Ortho Clinical Diagnostics Business Overview
11.15.3 Ortho Clinical Diagnostics Respiratory Syncytial Virus Diagnostics Introduction
11.15.4 Ortho Clinical Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
11.15.5 Ortho Clinical Diagnostics Recent Developments
11.16 Roche Diagnostics
11.16.1 Roche Diagnostics Company Details
11.16.2 Roche Diagnostics Business Overview
11.16.3 Roche Diagnostics Respiratory Syncytial Virus Diagnostics Introduction
11.16.4 Roche Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
11.16.5 Roche Diagnostics Recent Developments
11.17 Scienion
11.17.1 Scienion Company Details
11.17.2 Scienion Business Overview
11.17.3 Scienion Respiratory Syncytial Virus Diagnostics Introduction
11.17.4 Scienion Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
11.17.5 Scienion Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Respiratory Syncytial Virus Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Direct Fluorescent Antibody Method
Table 3. Key Players of Rapid Antigen Diagnostic Tests
Table 4. Key Players of Molecular Diagnostics
Table 5. Key Players of Chromatographic Immunoassay
Table 6. Key Players of Diagnostic Imaging
Table 7. Key Players of Gel Microdroplets
Table 8. Key Players of Flow Cytometry
Table 9. Key Players of Other
Table 10. Global Respiratory Syncytial Virus Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 11. Global Respiratory Syncytial Virus Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 12. Global Respiratory Syncytial Virus Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 13. Global Respiratory Syncytial Virus Diagnostics Market Share by Region (2017-2022)
Table 14. Global Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 15. Global Respiratory Syncytial Virus Diagnostics Market Share by Region (2023-2028)
Table 16. Respiratory Syncytial Virus Diagnostics Market Trends
Table 17. Respiratory Syncytial Virus Diagnostics Market Drivers
Table 18. Respiratory Syncytial Virus Diagnostics Market Challenges
Table 19. Respiratory Syncytial Virus Diagnostics Market Restraints
Table 20. Global Respiratory Syncytial Virus Diagnostics Revenue by Players (2017-2022) & (US$ Million)
Table 21. Global Respiratory Syncytial Virus Diagnostics Revenue Share by Players (2017-2022)
Table 22. Global Top Respiratory Syncytial Virus Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Syncytial Virus Diagnostics as of 2021)
Table 23. Ranking of Global Top Respiratory Syncytial Virus Diagnostics Companies by Revenue (US$ Million) in 2021
Table 24. Global 5 Largest Players Market Share by Respiratory Syncytial Virus Diagnostics Revenue (CR5 and HHI) & (2017-2022)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Respiratory Syncytial Virus Diagnostics Product Solution and Service
Table 27. Date of Enter into Respiratory Syncytial Virus Diagnostics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Respiratory Syncytial Virus Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 30. Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Type (2017-2022)
Table 31. Global Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 32. Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Type (2023-2028)
Table 33. Global Respiratory Syncytial Virus Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 34. Global Respiratory Syncytial Virus Diagnostics Revenue Share by Application (2017-2022)
Table 35. Global Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 36. Global Respiratory Syncytial Virus Diagnostics Revenue Share by Application (2023-2028)
Table 37. North America Respiratory Syncytial Virus Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 38. North America Respiratory Syncytial Virus Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 39. North America Respiratory Syncytial Virus Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 40. North America Respiratory Syncytial Virus Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 41. North America Respiratory Syncytial Virus Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 42. North America Respiratory Syncytial Virus Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 43. Europe Respiratory Syncytial Virus Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 44. Europe Respiratory Syncytial Virus Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 45. Europe Respiratory Syncytial Virus Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 46. Europe Respiratory Syncytial Virus Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 47. Europe Respiratory Syncytial Virus Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 48. Europe Respiratory Syncytial Virus Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 49. Asia Pacific Respiratory Syncytial Virus Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 50. Asia Pacific Respiratory Syncytial Virus Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 51. Asia Pacific Respiratory Syncytial Virus Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 52. Asia Pacific Respiratory Syncytial Virus Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 53. Asia Pacific Respiratory Syncytial Virus Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 54. Asia Pacific Respiratory Syncytial Virus Diagnostics Market Size by Region (2023-2028) & (US$ Million)
Table 55. Latin America Respiratory Syncytial Virus Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 56. Latin America Respiratory Syncytial Virus Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 57. Latin America Respiratory Syncytial Virus Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 58. Latin America Respiratory Syncytial Virus Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 59. Latin America Respiratory Syncytial Virus Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 60. Latin America Respiratory Syncytial Virus Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Respiratory Syncytial Virus Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Respiratory Syncytial Virus Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Respiratory Syncytial Virus Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Respiratory Syncytial Virus Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 65. Middle East and Africa Respiratory Syncytial Virus Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 66. Middle East and Africa Respiratory Syncytial Virus Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 67. Becton Dickinson Company Details
Table 68. Becton Dickinson Business Overview
Table 69. Becton Dickinson Respiratory Syncytial Virus Diagnostics Product
Table 70. Becton Dickinson Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022) & (US$ Million)
Table 71. Becton Dickinson Recent Developments
Table 72. Abbott Laboratories Company Details
Table 73. Abbott Laboratories Business Overview
Table 74. Abbott Laboratories Respiratory Syncytial Virus Diagnostics Product
Table 75. Abbott Laboratories Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022) & (US$ Million)
Table 76. Abbott Laboratories Recent Developments
Table 77. Abbott Company Details
Table 78. Abbott Business Overview
Table 79. Abbott Respiratory Syncytial Virus Diagnostics Product
Table 80. Abbott Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022) & (US$ Million)
Table 81. Abbott Recent Developments
Table 82. Beckman Coulter/Danaher Company Details
Table 83. Beckman Coulter/Danaher Business Overview
Table 84. Beckman Coulter/Danaher Respiratory Syncytial Virus Diagnostics Product
Table 85. Beckman Coulter/Danaher Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022) & (US$ Million)
Table 86. Beckman Coulter/Danaher Recent Developments
Table 87. Bio-Rad Laboratories Company Details
Table 88. Bio-Rad Laboratories Business Overview
Table 89. Bio-Rad Laboratories Respiratory Syncytial Virus Diagnostics Product
Table 90. Bio-Rad Laboratories Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022) & (US$ Million)
Table 91. Bio-Rad Laboratories Recent Developments
Table 92. Coris BioConcept Company Details
Table 93. Coris BioConcept Business Overview
Table 94. Coris BioConcept Respiratory Syncytial Virus Diagnostics Product
Table 95. Coris BioConcept Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022) & (US$ Million)
Table 96. Coris BioConcept Recent Developments
Table 97. DiaSorin SPA Company Details
Table 98. DiaSorin SPA Business Overview
Table 99. DiaSorin SPA Respiratory Syncytial Virus Diagnostics Product
Table 100. DiaSorin SPA Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022) & (US$ Million)
Table 101. DiaSorin SPA Recent Developments
Table 102. Eiken Chemical Company Details
Table 103. Eiken Chemical Business Overview
Table 104. Eiken Chemical Respiratory Syncytial Virus Diagnostics Product
Table 105. Eiken Chemical Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022) & (US$ Million)
Table 106. Eiken Chemical Recent Developments
Table 107. Elitech Company Details
Table 108. Elitech Business Overview
Table 109. Elitech Respiratory Syncytial Virus Diagnostics Product
Table 110. Elitech Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022) & (US$ Million)
Table 111. Elitech Recent Developments
Table 112. Fujirebio Company Details
Table 113. Fujirebio Business Overview
Table 114. Fujirebio Respiratory Syncytial Virus Diagnostics Product
Table 115. Fujirebio Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022) & (US$ Million)
Table 116. Fujirebio Recent Developments
Table 117. Grifols Company Details
Table 118. Grifols Business Overview
Table 119. Grifols Respiratory Syncytial Virus Diagnostics Product
Table 120. Grifols Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022) & (US$ Million)
Table 121. Grifols Recent Developments
Table 122. Hoffmann La Roche Company Details
Table 123. Hoffmann La Roche Business Overview
Table 124. Hoffmann La Roche Respiratory Syncytial Virus Diagnostics Product
Table 125. Hoffmann La Roche Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022) & (US$ Million)
Table 126. Hoffmann La Roche Recent Developments
Table 127. Hologic Company Details
Table 128. Hologic Business Overview
Table 129. Hologic Respiratory Syncytial Virus Diagnostics Product
Table 130. Hologic Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022) & (US$ Million)
Table 131. Hologic Recent Developments
Table 132. Novartis Diagnostics Company Details
Table 133. Novartis Diagnostics Business Overview
Table 134. Novartis Diagnostics Respiratory Syncytial Virus Diagnostics Product
Table 135. Novartis Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022) & (US$ Million)
Table 136. Novartis Diagnostics Recent Developments
Table 137. Ortho Clinical Diagnostics Company Details
Table 138. Ortho Clinical Diagnostics Business Overview
Table 139. Ortho Clinical Diagnostics Respiratory Syncytial Virus Diagnostics Product
Table 140. Ortho Clinical Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022) & (US$ Million)
Table 141. Ortho Clinical Diagnostics Recent Developments
Table 142. Roche Diagnostics Company Details
Table 143. Roche Diagnostics Business Overview
Table 144. Roche Diagnostics Respiratory Syncytial Virus Diagnostics Product
Table 145. Roche Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022) & (US$ Million)
Table 146. Roche Diagnostics Recent Developments
Table 147. Scienion Company Details
Table 148. Scienion Business Overview
Table 149. Scienion Respiratory Syncytial Virus Diagnostics Product
Table 150. Scienion Revenue in Respiratory Syncytial Virus Diagnostics Business (2017-2022) & (US$ Million)
Table 151. Scienion Recent Developments
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Respiratory Syncytial Virus Diagnostics Market Share by Type: 2021 VS 2028
Figure 2. Direct Fluorescent Antibody Method Features
Figure 3. Rapid Antigen Diagnostic Tests Features
Figure 4. Molecular Diagnostics Features
Figure 5. Chromatographic Immunoassay Features
Figure 6. Diagnostic Imaging Features
Figure 7. Gel Microdroplets Features
Figure 8. Flow Cytometry Features
Figure 9. Other Features
Figure 10. Global Respiratory Syncytial Virus Diagnostics Market Share by Application: 2021 VS 2028
Figure 11. Hospitals Case Studies
Figure 12. Laboratory Case Studies
Figure 13. Clinics Case Studies
Figure 14. Homecare Case Studies
Figure 15. Respiratory Syncytial Virus Diagnostics Report Years Considered
Figure 16. Global Respiratory Syncytial Virus Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 17. Global Respiratory Syncytial Virus Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Respiratory Syncytial Virus Diagnostics Market Share by Region: 2021 VS 2028
Figure 19. Global Respiratory Syncytial Virus Diagnostics Market Share by Players in 2021
Figure 20. Global Top Respiratory Syncytial Virus Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Syncytial Virus Diagnostics as of 2021)
Figure 21. The Top 10 and 5 Players Market Share by Respiratory Syncytial Virus Diagnostics Revenue in 2021
Figure 22. North America Respiratory Syncytial Virus Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 23. North America Respiratory Syncytial Virus Diagnostics Market Size Market Share by Type (2017-2028)
Figure 24. North America Respiratory Syncytial Virus Diagnostics Market Size Market Share by Application (2017-2028)
Figure 25. North America Respiratory Syncytial Virus Diagnostics Market Size Share by Country (2017-2028)
Figure 26. United States Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Canada Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Europe Respiratory Syncytial Virus Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 29. Europe Respiratory Syncytial Virus Diagnostics Market Size Market Share by Type (2017-2028)
Figure 30. Europe Respiratory Syncytial Virus Diagnostics Market Size Market Share by Application (2017-2028)
Figure 31. Europe Respiratory Syncytial Virus Diagnostics Market Size Share by Country (2017-2028)
Figure 32. Germany Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. France Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. U.K. Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Italy Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Russia Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Nordic Countries Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 39. Asia Pacific Respiratory Syncytial Virus Diagnostics Market Size Market Share by Type (2017-2028)
Figure 40. Asia Pacific Respiratory Syncytial Virus Diagnostics Market Size Market Share by Application (2017-2028)
Figure 41. Asia Pacific Respiratory Syncytial Virus Diagnostics Market Size Share by Region (2017-2028)
Figure 42. China Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Japan Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. South Korea Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Southeast Asia Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. India Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Australia Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 48. Latin America Respiratory Syncytial Virus Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Latin America Respiratory Syncytial Virus Diagnostics Market Size Market Share by Type (2017-2028)
Figure 50. Latin America Respiratory Syncytial Virus Diagnostics Market Size Market Share by Application (2017-2028)
Figure 51. Latin America Respiratory Syncytial Virus Diagnostics Market Size Share by Country (2017-2028)
Figure 52. Mexico Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Brazil Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa Respiratory Syncytial Virus Diagnostics Market Size Market Share by Type (2017-2028)
Figure 56. Middle East and Africa Respiratory Syncytial Virus Diagnostics Market Size Market Share by Application (2017-2028)
Figure 57. Middle East and Africa Respiratory Syncytial Virus Diagnostics Market Size Share by Country (2017-2028)
Figure 58. Turkey Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. Saudi Arabia Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 60. UAE Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 61. Becton Dickinson Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
Figure 62. Abbott Laboratories Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
Figure 63. Abbott Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
Figure 64. Beckman Coulter/Danaher Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
Figure 65. Bio-Rad Laboratories Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
Figure 66. Coris BioConcept Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
Figure 67. DiaSorin SPA Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
Figure 68. Eiken Chemical Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
Figure 69. Elitech Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
Figure 70. Fujirebio Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
Figure 71. Grifols Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
Figure 72. Hoffmann La Roche Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
Figure 73. Hologic Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
Figure 74. Novartis Diagnostics Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
Figure 75. Ortho Clinical Diagnostics Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
Figure 76. Roche Diagnostics Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
Figure 77. Scienion Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2017-2022)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
Industry Market Size
